How to Communicate With Vaccine-Hesitant Parents

被引:110
作者
Healy, C. Mary [3 ,4 ]
Pickering, Larry K. [1 ,2 ]
机构
[1] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA
[2] Emory Univ, Sch Med, Atlanta, GA USA
[3] Texas Childrens Hosp, Ctr Vaccine Awareness & Res, Houston, TX 77030 USA
[4] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA
关键词
vaccine safety; health care providers; THIMEROSAL-CONTAINING VACCINES; HEALTH-CARE PROVIDERS; DEVELOPMENTAL DISORDERS; CHILDHOOD VACCINES; UNITED-KINGDOM; MEASLES-VIRUS; MEDICAL HOME; NO EVIDENCE; AUTISM; IMMUNIZATION;
D O I
10.1542/peds.2010-1722S
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Development of safe and effective vaccines is one the greatest medical triumphs. However, despite high immunization rates in the United States, 85% of health care providers (HCPs) will have a parent refuse a vaccine for his or her child each year. HCPs have the greatest influence on a parent's decision to vaccinate his or her child. To effectively communicate with vaccine-hesitant parents, HCPs must first understand the concerns of parents regarding immunization and understand influences that can lead to misinformation about the safety and effectiveness of vaccines. HCPs should establish an open, nonconfrontational dialogue with vaccine-hesitant parents at an early stage and provide unambiguous, easily comprehensible answers about known vaccine adverse events and provide accurate information about vaccination. Personal stories and visual images of patients and parents affected by vaccine-preventable diseases and reports of disease outbreaks serve as useful reminders of the need to maintain high immunization rates. Ongoing dialogue including provider recommendations may successfully reassure vaccine-hesitant parents that immunization is the best and safest option for their child. Pediatrics 2011;127:S127-S133
引用
收藏
页码:S127 / S133
页数:7
相关论文
共 56 条
[1]   The association of health insurance and continuous primary care in the medical home on vaccination coverage for 19-to 35-month-old children [J].
Allred, Norma J. ;
Wooten, Karen G. ;
Kong, Yuan .
PEDIATRICS, 2007, 119 :S4-S11
[2]   Thimerosal exposure in infants and developmental disorders: A retrospective cohort study in the United Kingdom does not support a causal association [J].
Andrews, N ;
Miller, E ;
Grant, A ;
Stowe, J ;
Osborne, V ;
Taylor, B .
PEDIATRICS, 2004, 114 (03) :584-591
[3]   Measles vaccination and antibody response in autism spectrum disorders [J].
Baird, G. ;
Pickles, A. ;
Simonoff, E. ;
Charman, T. ;
Sullivan, P. ;
Chandler, S. ;
Loucas, T. ;
Meldrum, D. ;
Afzal, M. ;
Thomas, B. ;
Jin, L. ;
Brown, D. .
ARCHIVES OF DISEASE IN CHILDHOOD, 2008, 93 (10) :832-837
[4]  
Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P563
[5]   Vaccine safety: Current and future challenges [J].
Chen, RT ;
Hibbs, B .
PEDIATRIC ANNALS, 1998, 27 (07) :445-455
[6]   Best practices in public health risk and crisis communication [J].
Covello, VT .
JOURNAL OF HEALTH COMMUNICATION, 2003, 8 :5-8
[7]  
Covello VT, 2003, J HLTH COMMUN S1, V8, P148, DOI DOI 10.1080/713851971
[8]   No evidence of persisting measles virus in peripheral blood mononuclear cells from children with autism spectrum disorder [J].
D'Souza, Yasmin ;
Fombonne, Eric ;
Ward, Brian J. .
PEDIATRICS, 2006, 118 (04) :1664-1675
[9]   Responding to parental refusals of immunization of children [J].
Diekema, DS .
PEDIATRICS, 2005, 115 (05) :1428-1431
[10]  
Eggers P., 2006, Morbidity and Mortality Weekly Report, V55, P817